CTLA4 and neoplasm: For this, we labeled B16 cells using serum from mice rendered disease-free from a B78 melanoma tumor by treatment with RT + IT-IC + anti-CTLA-4 and demonstrating immune memory by rejection at D90 of re-implantation with B78.